IONS

Ionis Pharmaceuticals, Inc. Common Stock

XNAS · PHARMACEUTICAL PREPARATIONS · PHARMACEUTICAL PREPARATIONS

1 article0 insider tx0 holders0 supply chain0 selling intent filings0 new insiders

Research articles

Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.

earnings_report

TL;DR: Ionis posted $246 million in Q1 2026 revenue, up 86.4% from $132 million in the same quarter last year.

5/11/2026 · 0 views

Want deeper analysis?

Investabot monitors SEC filings daily and generates institutional-grade research on insider trades, risk factors, supply chains, and more.